Emerging data with immunotherapy in ESCC and potential impact for clinical practice

touchTALKS for touchONCOLOLOGY Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)  The expert: Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK Overview: Part 1: Insights from 2021 (0:00) Part 2: Insights from ASCO and ESMO GI 2022 (13:29) Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08) Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53) This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.  For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023